FDA accepts Blue Earth's PET agent application

By AuntMinnie.com staff writers

December 2, 2015 -- Blue Earth Diagnostics announced that its new drug application (NDA) filing for the PET agent fluciclovine has been accepted by the U.S. Food and Drug Administration (FDA) for priority review.

The firm is seeking U.S. marketing approval of fluciclovine (F-18) for lesion detection and localization for prostate cancer patients experiencing biochemical recurrence. Fluciclovine is a synthetic amino acid investigational PET radiopharmaceutical being studied by Blue Earth in the imaging of various cancers, with its lead product being in prostate cancer. The NDA submission for fluciclovine is based on data from more than 700 prostate cancer patients, most with biochemical recurrence and some with high-risk primary disease, imaged in the U.S., Norway, and Italy.

If approved, Siemens Healthcare subsidiary PETNet Solutions will manufacture, distribute, and sell the radiopharmaceutical in the U.S.

PETNet develops biomarker for prostate, breast cancer
Siemens Healthcare subsidiary PETNet Solutions said it will produce a new investigational molecular biomarker for use in clinical trials on behalf of...
PETNet gets approval for PET agent
PETNet Solutions has received approval from the U.S. Food and Drug Administration (FDA) for an abbreviated new drug application for its sodium fluoride...
Blue Earth secures $28M in venture capital
Blue Earth Diagnostics has received $27.9 million (25.4 million euros) in capital from U.K. venture fund Syncona Partners.
Blue Earth gets orphan drug status
Blue Earth Diagnostics has received two orphan drug designations for its F-18 fluciclovine radiopharmaceutical for diagnosing glioma.
PETNet to offer PET prostate tracer
Siemens Healthcare said its PETNet Solutions subsidiary will begin offering a prostate cancer radiotracer for use in clinical trials in the New York City...
PETNet, Blue Earth ink prostate PET agent deal
PETNet Solutions has inked an agreement with Blue Earth Diagnostics for the exclusive manufacturing and distribution of a radiopharmaceutical for PET/CT...

Copyright © 2015 AuntMinnie.com